Anatomy of an IPO. Every figure read from a filing
SYMBIOTEC PHARMALAB LIMITED
IssueRs 1,757 cr
Amount of issue size: 17,57,00,00,000
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD AMOUNT OF ISSUE SIZE
PriceRs 988
Issue Price for the current Public issue Rs. 988/- per share
BSE NOTICE 20260831-26 P.2 · SHA256 9DF35835 · NOTICE ISSUE PRICE
Lot15 sh / Rs 14,820
Market lot: 15
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD MARKET LOT
Allotted28 Aug 2026
Date of Allotment in the public issue: August 28, 2026
BSE NOTICE 20260831-26 P.2 · SHA256 9DF35835 · NOTICE DATE OF ALLOTMENT
Listed1 Sep 2026
Date of listing: 2026-09-01
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD DATE OF LISTING
Last closeRs 1,176.05 · +19.0%
21 trading day(s) from 2026-09-01 to 2026-09-30. Closed at 1095.95 on the first day held and 1176.05 on the last, up 7.3% between them. Issued at 988.
BSE DAILY PRICES, SCRIP 544889 P.1 · SHA256 45200D81 · BSE STOCK PRICE CSV
01 Who was given shares, and on what terms
Anchor investors29.94%
Number of share allocated to anchor: 53,25,909
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD SHARES ALLOCATED TO ANCHOR
ALLOCATED BEFORE BIDDING OPENED, AT A PRICE NOBODY BID · RS 526 CRORE
Other institutions19.96%
Number of share allocated to QIB: 35,50,607
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD ALLOCATED TO QIB
QUALIFIED INSTITUTIONAL BUYERS, NET OF THE ANCHOR PORTION
Wealthy individuals14.97%
Number of share allocated to NII: 26,62,956
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD ALLOCATED TO NII
NON-INSTITUTIONAL, THE PORTION ABOVE TWO LAKH RUPEES
People like you34.93%
Number of share allocated to RII: 62,13,563
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD ALLOCATED TO RII
RETAIL. GUARANTEED BY LAW WHETHER OR NOT ANYONE WANTS IT
The odds of an application getting shares need the retail subscription, which comes from the bid book while bidding runs. This issue listed before this site began holding books, and the exchange withdraws the book at close, so for this issue it no longer exists anywhere.
Reserved portion0.19%
Number of share allocated to reservation portion: 33,407
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD ALLOCATED TO RESERVATION
EMPLOYEES OR SHAREHOLDERS OF THE ISSUER
02 The issue, and where the money went
1,77,86,442 shares offered
Number of issue shares: 1,77,86,442
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD NUMBER OF ISSUE SHARES
Rs 1,757
crore
Amount of issue size: 17,57,00,00,000
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD AMOUNT OF ISSUE SIZE
BIDDING 24 AUG 2026 TO 27 AUG 2026 PRICE FIXED AT RS 988
03 Where the money came out
100% of the money
Partly to the company, partly to selling shareholders
Rs 1,757 crore
COMPOSITION FRESH AND OFS · 1,62,65,181 SHARES SOLD BY EXISTING HOLDERS
Number of offer for sale shares: 1,62,65,181
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD OFFER FOR SALE SHARES
Rs 150 crore
to the company
THE FRESH ISSUE PORTION, AT THE ISSUE PRICE.
What the company will do with it
The objects of the offer are complete only in the final prospectus. A red herring states the fixed objects and leaves the residual one and the total blank, because both depend on the price.
04 What the company earns
FY 2026Rs 869.15 croreRs 109.90 crore profit for the year · 12.6% of revenueFY 2025Rs 751.55 croreRs 96.79 crore profit for the year · 12.9% of revenueFY 2024Rs 716.25 croreRs 100.06 crore profit for the year · 14.0% of revenueWhat the filing states about the latest year · FY 2026
EBITDARs 231.97 croreEBITDA margin26.59%Return on net worthnot stated in a table that checks outReturn on capital employednot stated in a table that checks outDebt to equitynot stated in a table that checks outCurrent rationot stated in a table that checks outNet worthnot stated in a table that checks outRead from the key performance indicators
What the filing states about the latest year · FY 2026
Read from the key performance indicators
5 indicator(s) over 2026, 2025, 2024: Revenue from operations (1) 2026 Rs 869.15 crore, 2025 Rs 751.55 crore, 2024 Rs 716.25 crore
SYMBIOTEC PHARMALAB LIMITED – RHP P.151 · SHA256 AC727F65 · KEY PERFORMANCE INDICATORS
05 When those shares come back to the market
- 28 Aug 2026ALLOTMENT
- 1 Sep 2026LISTED
- 27 Sep 2026Anchor lock-in, first trancheRs 263 crore · 26,62,955 SHARES UNLOCK
- 26 Nov 2026Anchor lock-in, second trancheRs 263 crore · 26,62,954 SHARES UNLOCK
06 Every dated unlock, with the page it was read from
Anchor lock-in, first tranche
28 Sep 2026
ICDR Sch XIII Pt A Cl.10(j) · 30 days
Shares: 26,62,955
At the issue price: Rs 263.10 crore
Closed at Rs 1,056.75 · +5.4% the day before
Source: BSE issue summary, scrip 544889 p.1 b35710db
Number of share allocated to anchor: 53,25,909
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD SHARES ALLOCATED TO ANCHOR
Period: 30 days
locked in for a period of 30 days from the date of Allotment
SYMBIOTEC PHARMALAB LIMITED – RHP P.463 · SHA256 AC727F65 · STATED ANCHOR FIRST TRANCHE
Anchor lock-in, second tranche
26 Nov 2026
ICDR Sch XIII Pt A Cl.10(j) · 90 days
Shares: 26,62,954
At the issue price: Rs 263.10 crore
Source: BSE issue summary, scrip 544889 p.1 b35710db
Number of share allocated to anchor: 53,25,909
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · ISD SHARES ALLOCATED TO ANCHOR
Period: 90 days
90 days from the date of Allotment
SYMBIOTEC PHARMALAB LIMITED – RHP P.463 · SHA256 AC727F65 · STATED ANCHOR SECOND TRANCHE
Not dated on this page, and why
- Minimum promoters' contribution: the prospectus does not state the minimum promoters' contribution period in a form this reader recognises, and the period depends on whether the proceeds fund capital expenditure
- Promoter holding above the minimum: the promoters' total holding after the offer, which this lock-in is that total less the minimum contribution, was not read from the capital structure summary, or the contribution itself was not
- Pre-IPO non-promoter lock-in: everything locked for six months that is not the promoters own holding follows by arithmetic from the post-issue capital, the offer and the promoters holding, all of which are here, except for the shares the regulation exempts from lock-in, which no filing in this store states as a count. Without that count the figure would be an upper bound rather than a figure, so it is not published
29.94% of this issue was allocated before the public could bid, at a price nobody bid.
BSE ISSUE SUMMARY, SCRIP 544889 P.1 · SHA256 B35710DB · NOTHING HERE IS ADVICE.
Free forever. No advertising, no affiliate links, no paid tier. No grey market premium. No scores, no ratings. Nothing here is investment advice.